Bioworld Insider

Extending the human lifespan

In Extending the human lifespan, a BioWorld special report, the team examined the latest science, the key biological drivers that can be targeted pharmacologically and the companies developing potential “Fountain of Youth” candidate drugs. In this episode of the BioWorld Insider Podcast, the team discussed the report’s highlights and key takeaways.  In what could be a holy grail for humanity, anti-aging drugs would simultaneously reduce the risk of multiple age-related illnesses in one. BioWorld found that investments in life-extending drugs and the number of clinical trials are on the rise. Can we hopscotch over the many diseases of aging? The impact could be staggering. Equitable access to drugs and therapies tackling aging could reduce health care costs in a major way and improve quality of life.

Mari Serebrov
Bioworld regulatory editor
Clarivate
Karen Carey
Bioworld analyst
Clarivate
Richard Staines
Bioworld staff writer
Clarivate
Anette Breindl
Bioworld senior science editor
Clarivate

Episodes